Find Alpidem manufacturers, exporters & distributors on PharmaCompass

Alpidem

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 82626-01-5, Ananxyl, 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide, Sl 80.0342-00, 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide, 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide

Molecular Formula

C₂₁H₂₃Cl₂N₃O

Molecular Weight

404.3 g/mol

InChI Key

JRTIDHTUMYMPRU-UHFFFAOYSA-N

FDA UNII

I93SC245QZ

1 2D Structure

Alpidem

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

2.1.2 InChI

InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3

2.1.3 InChI Key

JRTIDHTUMYMPRU-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl

2.2 Other Identifiers

2.2.1 UNII

I93SC245QZ

2.3 Synonyms

2.3.1 MeSH Synonyms

1. S-800342

2. Sl 80-0342

2.3.2 Depositor-Supplied Synonyms

1. 82626-01-5

2. Ananxyl

3. 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide

4. Sl 80.0342-00

5. 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide

6. 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide

7. Chembl54349

8. I93sc245qz

9. Sl-80.0342-00

10. 6-chlor-2-(4-chlorphenyl)-n,n-dipropylimidazol(1,2-a)pyridin-3-acetamid

11. Alpidemum [latin]

12. Ncgc00182850-01

13. Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-n,n-dipropyl-

14. Dsstox_cid_28972

15. Dsstox_rid_83237

16. Dsstox_gsid_49046

17. Alpidemum

18. Cas-82626-01-5

19. Alpidem [usan:inn:ban]

20. Unii-i93sc245qz

21. S-800342

22. Alpidem-[d14]

23. Alpidem (usan/inn)

24. Alpidem [usan]

25. Alpidem [inn]

26. Alpidem [mi]

27. Alpidem [mart.]

28. Alpidem [who-dd]

29. Schembl122619

30. Dtxsid8049046

31. Bdbm22041

32. Chebi:135649

33. Zinc599598

34. Tox21_113593

35. Alpidem, >=98% (hplc), Powder

36. Pdsp1_000633

37. Pdsp2_000628

38. Akos016014168

39. Tox21_113593_1

40. Cs-w013866

41. Hy-w013150

42. Ncgc00182850-02

43. Ft-0630911

44. D02833

45. A930152

46. Sr-01000944944

47. Q4735440

48. Sr-01000944944-1

49. 2-(6-chloro-2-(4-chlorophenyl)h-imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₃Cl₂N₃O
Molecular Weight	404.3 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	7
Exact Mass	403.1218178 g/mol
Monoisotopic Mass	403.1218178 g/mol
Topological Polar Surface Area	37.6 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	478
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)

API SUPPLIERS